Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Short

Showing results (41-50 of 659) with videos related to

Pageof 66
Sort By:
International Journal of Obstetric Anesthesia|August 24, 2004
Pressure sores following epidural analgesia in labourJ Short, E A Ryall
American Journal of Hematology|September 25, 2024
Measurable residual disease monitoring in AML: Prospects for therapeutic decision-making and new drug developmentNicholas J Short, Richard Dillon
Clinical Advances in Hematology & Oncology : H&O|July 28, 2017
Yes, treatment for CML should continue indefinitelyNicholas J Short, Elias Jabbour
Clinics in Podiatric Medicine and Surgery|June 4, 2017
Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and AnkleDaniel J Short, Thomas Zgonis
Acta Haematologica|July 29, 2025
Advances in Acute Lymphoblastic Leukemia Review SeriesJayastu Senapati, Nicholas J Short
Clinical Advances in Hematology & Oncology : H&O|December 9, 2016
Should treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia be intensive? Intensive treatment is the best treatment for these patientsNicholas J Short, Elias Jabbour
The Journal of Nursing Administration|May 1, 1979
Nursing input to nursing unit designJ Grubbs, S J Short
Current Oncology Reports|February 17, 2017
Minimal Residual Disease in Acute Lymphoblastic Leukemia: How to Recognize and Treat ItNicholas J Short, Elias Jabbour
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Acute Myeloid Leukemia: Past, Present, and Prospects for the FutureNicholas J Short, Farhad Ravandi
The Lancet. Haematology|June 30, 2022
Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemiaNicholas J Short, Hagop Kantarjian
Pageof 66

Showing results (41-50 of 659) with videos related to

Sort By:
Pageof 66
International Journal of Obstetric Anesthesia|August 24, 2004
Pressure sores following epidural analgesia in labourJ Short, E A Ryall
American Journal of Hematology|September 25, 2024
Measurable residual disease monitoring in AML: Prospects for therapeutic decision-making and new drug developmentNicholas J Short, Richard Dillon
Clinical Advances in Hematology & Oncology : H&O|July 28, 2017
Yes, treatment for CML should continue indefinitelyNicholas J Short, Elias Jabbour
Clinics in Podiatric Medicine and Surgery|June 4, 2017
Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and AnkleDaniel J Short, Thomas Zgonis
Acta Haematologica|July 29, 2025
Advances in Acute Lymphoblastic Leukemia Review SeriesJayastu Senapati, Nicholas J Short
Clinical Advances in Hematology & Oncology : H&O|December 9, 2016
Should treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia be intensive? Intensive treatment is the best treatment for these patientsNicholas J Short, Elias Jabbour
The Journal of Nursing Administration|May 1, 1979
Nursing input to nursing unit designJ Grubbs, S J Short
Current Oncology Reports|February 17, 2017
Minimal Residual Disease in Acute Lymphoblastic Leukemia: How to Recognize and Treat ItNicholas J Short, Elias Jabbour
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Acute Myeloid Leukemia: Past, Present, and Prospects for the FutureNicholas J Short, Farhad Ravandi
The Lancet. Haematology|June 30, 2022
Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemiaNicholas J Short, Hagop Kantarjian
Pageof 66